CDC's vaccine advisory committee to vote on RSV, flu shots

ReutersJun 18, 2025 3:15 PM

June 18 (Reuters) - The U.S. Centers for Disease Control and Prevention panel of vaccine experts will vote on shots for respiratory syncytial virus and influenza at a meeting scheduled for June 25 and 26, according to the agency's website.

The panel will also discuss and vote on flu vaccines containing thimerosal, which is a widely used preservative that contains mercury.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

SanDisk Surges 8% as Earnings Countdown Begins - Here's What Every Investor Needs to Know

TradingKey - SanDisk(SNDK) is really on the move ahead of its earnings April 30th release, and the company's price action over the past few days is telling us there's something specific going on . It's currently up 8.11%, yesterday it jumped by 6.16%. A year ago it was hovering around the $28 mark,

Nvidia Stock Prediction: Can NVDA Hit $1,000 by 2030?

Nvidia remains a “Strong Buy” for those who believe cumulative AI infrastructure spending will reach the projected $3 trillion to $7 trillion by 2030. However, investors must be prepared for "wild swings" as the market transitions from AI hype to tangible AI utility.

Robinhood Slumps 8% After Earnings. Revenue and Profit Both Miss, Market Fears Coinbase May Follow Suit.

Robinhood’s earnings miss triggered a sharp decline in its stock price and intensified market concerns regarding Coinbase.

Deep Analysis 48 Hours Before Microsoft Earnings: OpenAI Agreement Restructuring Implemented, Three Variables of Azure, Copilot, and Capital Expenditure Determine MSFT Valuation Recovery Path

Microsoft released its FY26 Q3 earnings on April 29. This article provides an in-depth analysis of the impact of the OpenAI agreement restructuring, examining three key metrics—Azure growth, a 3.3% Copilot penetration rate, and $110 billion in capital expenditure—to determine whether MSFT’s forward P/E of 22x offers a long-term positioning opportunity.

Microsoft 2026 Q3 Earnings Preview: Can Azure’s Growth Momentum Keep Up With Massive AI Capital Spending?

TradingKey - Microsoft (MSFT) is scheduled to release its Q3 FY2026 earnings report after the market close on April 29, ET. As one of the most proactive tech giants in advancing global AI strategies, this report is regarded as a key indicator for evaluating the large-scale monetization of AI technology and the growth resilience of its cloud business.

Featured Tools